Nanobead-based interventions for the treatment and prevention of tuberculosis
|
journal
|
October 2010 |
A methodology for performing global uncertainty and sensitivity analysis in systems biology
|
journal
|
September 2008 |
The mutation rate of mycobacterial repetitive unit loci in strains of M. tuberculosis from cynomolgus macaque infection
|
journal
|
January 2013 |
SOCS3 Deficiency Promotes M1 Macrophage Polarization and Inflammation
|
journal
|
August 2012 |
Multiscale Computational Modeling Reveals a Critical Role for TNF-α Receptor 1 Dynamics in Tuberculosis Granuloma Formation
|
journal
|
February 2011 |
Lack of IL-10 alters inflammatory and immune responses during pulmonary Mycobacterium tuberculosis infection
|
journal
|
March 2009 |
TB or Not TB: That Is No Longer the Question
|
journal
|
November 2013 |
The Role of the Granuloma in Expansion and Dissemination of Early Tuberculous Infection
|
journal
|
January 2009 |
Cytokine Response Is Determined by Duration of Receptor and Signal Transducers and Activators of Transcription 3 (STAT3) Activation
|
journal
|
November 2012 |
Exploring the collaboration between antibiotics and the immune response in the treatment of acute, self-limiting infections
|
journal
|
May 2014 |
Inhaled drug therapy for treatment of tuberculosis
|
journal
|
January 2011 |
Understanding Latent Tuberculosis: A Moving Target
|
journal
|
June 2010 |
Mechanistic systems modeling to guide drug discovery and development
|
journal
|
February 2013 |
Differential Risk of Tuberculosis Reactivation among Anti-TNF Therapies Is Due to Drug Binding Kinetics and Permeability
|
journal
|
February 2012 |
The Immune Response in Tuberculosis
|
journal
|
March 2013 |
Tuberculosis vaccines: Time to think about the next generation
|
journal
|
April 2013 |
Granulomatous Infectious Diseases Associated with Tumor Necrosis Factor Antagonists
|
journal
|
May 2004 |
New old challenges in tuberculosis: Potentially effective nanotechnologies in drug delivery
|
journal
|
March 2010 |
Multi-Scale Modeling Predicts a Balance of Tumor Necrosis Factor-α and Interleukin-10 Controls the Granuloma Environment during Mycobacterium tuberculosis Infection
|
journal
|
July 2013 |
A metabolic network approach for the identification and prioritization of antimicrobial drug targets
|
journal
|
March 2012 |
Probing Gene Regulatory Networks to Decipher Host–Pathogen Interactions
|
book
|
October 2012 |
13C Metabolic Flux Analysis Identifies an Unusual Route for Pyruvate Dissimilation in Mycobacteria which Requires Isocitrate Lyase and Carbon Dioxide Fixation
|
journal
|
July 2011 |
A Systems Biology Approach for Understanding Granuloma Formation and Function in Tuberculosis
|
book
|
October 2012 |
Mathematical modeling of pulmonary tuberculosis therapy: Insights from a prototype model with rifampin
|
journal
|
August 2011 |
Variability in the population pharmacokinetics of isoniazid in South African tuberculosis patients: Population pharmacokinetics of isoniazid
|
journal
|
June 2011 |
TNF and IL-10 are major factors in modulation of the phagocytic cell environment in lung and lymph node in tuberculosis: A next-generation two-compartmental model
|
journal
|
August 2010 |
The Mycobacterium tuberculosis regulatory network and hypoxia
|
journal
|
July 2013 |
Predicting lymph node output efficiency using systems biology
|
journal
|
October 2013 |
Mycobacterium tuberculosis Inhibits Neutrophil Apoptosis, Leading to Delayed Activation of Naive CD4 T cells
|
journal
|
January 2012 |
Pharmacodynamic Functions: a Multiparameter Approach to the Design of Antibiotic Treatment Regimens
|
journal
|
September 2004 |
In Silico Children and the Glass Mouse Model: Clinical Trial Simulations To Identify and Individualize Optimal Isoniazid Doses in Children with Tuberculosis
|
journal
|
November 2010 |
The role of IL-10 in immune regulation during M. tuberculosis infection
|
journal
|
March 2011 |
Mathematical modeling of drug delivery
|
journal
|
December 2008 |
M. tuberculosis persistence, latency, and drug tolerance
|
journal
|
January 2004 |
Sterilization of granulomas is common in active and latent tuberculosis despite within-host variability in bacterial killing
|
journal
|
December 2013 |
Identification of Key Processes that Control Tumor Necrosis Factor Availability in a Tuberculosis Granuloma
|
journal
|
May 2010 |
A multistage tuberculosis vaccine that confers efficient protection before and after exposure
|
journal
|
January 2011 |
Recent advances towards tuberculosis control: vaccines and biomarkers
|
journal
|
April 2014 |
Mass spectrometry imaging of levofloxacin distribution in TB-infected pulmonary lesions by MALDI-MSI and continuous liquid microjunction surface sampling
|
journal
|
February 2015 |
Immunotherapeutics for Tuberculosis in Experimental Animals: Is There a Common Pathway Activated by Effective Protocols?
|
journal
|
July 2007 |
CD69 acts downstream of interferon-α/β to inhibit S1P1 and lymphocyte egress from lymphoid organs
|
journal
|
March 2006 |
Time-kill kinetics of anti-tuberculosis drugs, and emergence of resistance, in relation to metabolic activity of Mycobacterium tuberculosis
|
journal
|
October 2010 |
Tuberculosis vaccines – rethinking the current paradigm
|
journal
|
August 2014 |
A modeling analysis of the effects of molecular size and binding affinity on tumor targeting
|
journal
|
October 2009 |
American Thoracic Society/Centers for Disease Control and Prevention/Infectious Diseases Society of America
Treatment of Tuberculosis
|
journal
|
February 2003 |
Updating and curating metabolic pathways of TB
|
journal
|
January 2013 |
High endothelial venules (HEVs): specialized endothelium for lymphocyte migration
|
journal
|
September 1995 |
The population dynamics of antimicrobial chemotherapy.
|
journal
|
February 1997 |
Advances in the development of new tuberculosis drugs and treatment regimens
|
journal
|
April 2013 |
A Model to Predict Cell-Mediated Immune Regulatory Mechanisms During Human Infection with Mycobacterium tuberculosis
|
journal
|
February 2001 |
The Roles of Immune Memory and Aging in Protective Immunity and Endogenous Reactivation of Tuberculosis
|
journal
|
April 2013 |
Tumor Necrosis Factor Blockade in Chronic Murine Tuberculosis Enhances Granulomatous Inflammation and Disorganizes Granulomas in the Lungs
|
journal
|
January 2008 |
An essential role for interferon gamma in resistance to Mycobacterium tuberculosis infection
|
journal
|
December 1993 |
Why Is Long-Term Therapy Required to Cure Tuberculosis?
|
journal
|
March 2007 |
Targeting Persisters for Tuberculosis Control
|
journal
|
March 2012 |
Metabolic network analysis predicts efficacy of FDA-approved drugs targeting the causative agent of a neglected tropical disease
|
journal
|
January 2012 |
Differences in Reactivation of Tuberculosis Induced from Anti-TNF Treatments Are Based on Bioavailability in Granulomatous Tissue
|
journal
|
January 2007 |
A hybrid multi-compartment model of granuloma formation and T cell priming in Tuberculosis
|
journal
|
July 2011 |
The spectrum of latent tuberculosis: rethinking the biology and intervention strategies
|
journal
|
October 2009 |
The path of anti-tuberculosis drugs: from blood to lesions to mycobacterial cells
|
journal
|
February 2014 |
A computational tool integrating host immunity with antibiotic dynamics to study tuberculosis treatment
|
journal
|
February 2015 |
Rifampicin concentrations in bronchial mucosa, epithelial lining fluid, alveolar macrophages and serum following a single 600 mg oral dose in patients undergoing fibre-optic bronchoscopy
|
journal
|
November 2002 |
Pharmacokinetic Evaluation of the Penetration of Antituberculosis Agents in Rabbit Pulmonary Lesions
|
journal
|
October 2011 |
Tuberculous Granulomas Are Hypoxic in Guinea Pigs, Rabbits, and Nonhuman Primates
|
journal
|
March 2008 |
Mathematical modeling and simulation of drug release from microspheres: Implications to drug delivery systems
|
journal
|
November 2006 |
Tumor Necrosis Factor Blockers Influence Macrophage Responses to Mycobacterium tuberculosis
|
journal
|
December 2008 |
I MMUNOLOGY OF T UBERCULOSIS
|
journal
|
April 2001 |
Treatment of tuberculosis and optimal dosing schedules
|
journal
|
December 2010 |
Synergy between Individual TNF-Dependent Functions Determines Granuloma Performance for Controlling Mycobacterium tuberculosis Infection
|
journal
|
March 2009 |
Infection of Human Macrophages and Dendritic Cells with Mycobacterium tuberculosis Induces a Differential Cytokine Gene Expression That Modulates T Cell Response
|
journal
|
June 2001 |
Metronidazole prevents reactivation of latent Mycobacterium tuberculosis infection in macaques
|
journal
|
July 2012 |
Implementation of a transit compartment model for describing drug absorption in pharmacokinetic studies
|
journal
|
July 2007 |
Interleukin 10 Produced by Macrophages Inoculated with Mycobacterium avium Attenuates Mycobacteria‐Induced Apoptosis by Reduction of TNF‐α Activity
|
journal
|
October 1999 |
Population Pharmacokinetics and its Role in Anti-Tuberculosis Drug Development and Optimization of Treatment
|
journal
|
September 2011 |
Advances in Immunotherapy for Tuberculosis Treatment
|
journal
|
December 2009 |
The potent bactericidal activity of streptomycin in the guinea pig model of tuberculosis ceases due to the presence of persisters
|
journal
|
August 2010 |
Comparative Pharmacokinetics and Pharmacodynamics of the Rifamycin Antibacterials
|
journal
|
January 2001 |
Strategies against multidrug-resistant tuberculosis
|
journal
|
July 2002 |
13C-Flux Spectral Analysis of Host-Pathogen Metabolism Reveals a Mixed Diet for Intracellular Mycobacterium tuberculosis
|
journal
|
August 2013 |
Inhaled Drug Delivery for Tuberculosis Therapy
|
journal
|
September 2009 |
Latent tuberculosis: what the host “sees”?
|
journal
|
June 2011 |
Macrophage deactivation by interleukin 10.
|
journal
|
December 1991 |
Lessons from experimental Mycobacterium tuberculosis infections
|
journal
|
April 2006 |
A model of isoniazid treatment of tuberculosis
|
journal
|
December 2014 |
NF-κB Signaling Dynamics Play a Key Role in Infection Control in Tuberculosis
|
journal
|
January 2012 |
High-Sensitivity MALDI-MRM-MS Imaging of Moxifloxacin Distribution in Tuberculosis-Infected Rabbit Lungs and Granulomatous Lesions
|
journal
|
March 2011 |
Regulation and Functions of the IL-10 Family of Cytokines in Inflammation and Disease
|
journal
|
April 2011 |
Identifying control mechanisms of granuloma formation during M. tuberculosis infection using an agent-based model
|
journal
|
December 2004 |
Reconsidering Adjuvant Immunotherapy for Tuberculosis
|
journal
|
July 2005 |
Characterizing the Dynamics of CD4+ T Cell Priming within a Lymph Node
|
journal
|
February 2010 |
A simple in vitro PK/PD model system to determine time–kill curves of drugs against Mycobacteria
|
journal
|
September 2009 |
I NTERLEUKIN -10 AND THE I NTERLEUKIN -10 R ECEPTOR
|
journal
|
April 2001 |
Mining large-scale response networks reveals ‘topmost activities’ in Mycobacterium tuberculosis infection
|
journal
|
July 2013 |
Analysis of Combination Drug Therapy to Develop Regimens with Shortened Duration of Treatment for Tuberculosis
|
journal
|
July 2014 |
Microenvironments in Tuberculous Granulomas Are Delineated by Distinct Populations of Macrophage Subsets and Expression of Nitric Oxide Synthase and Arginase Isoforms
|
journal
|
June 2013 |
Investigating the metabolic capabilities of Mycobacterium tuberculosis H37Rv using the in silico strain iNJ 661 and proposing alternative drug targets
|
journal
|
June 2007 |
Isoniazid Pharmacokinetics-Pharmacodynamics in an Aerosol Infection Model of Tuberculosis
|
journal
|
July 2004 |
Quantitative Comparison of Active and Latent Tuberculosis in the Cynomolgus Macaque Model
|
journal
|
July 2009 |
The multistage vaccine H56 boosts the effects of BCG to protect cynomolgus macaques against active tuberculosis and reactivation of latent Mycobacterium tuberculosis infection
|
journal
|
January 2012 |
Strategies for Efficient Numerical Implementation of Hybrid Multi-scale Agent-Based Models to Describe Biological Systems
|
journal
|
November 2014 |
Computational Modeling Predicts IL-10 Control of Lesion Sterilization by Balancing Early Host Immunity–Mediated Antimicrobial Responses with Caseation during Mycobacterium tuberculosis Infection
|
journal
|
December 2014 |
Single-cell NF-κB dynamics reveal digital activation and analogue information processing
|
journal
|
June 2010 |
Modelling the effects of pre-exposure and post-exposure vaccines in tuberculosis control
|
journal
|
October 2008 |
Early Events in Mycobacterium tuberculosis Infection in Cynomolgus Macaques
|
journal
|
June 2006 |
Radiologic Responses in Cynomolgus Macaques for Assessing Tuberculosis Chemotherapy Regimens
|
journal
|
June 2013 |
The Effect of Directly Observed Therapy on the Rates of Drug Resistance and Relapse in Tuberculosis
|
journal
|
April 1994 |
Schedule or Dosage?: The Need to Perfect Intermittent Regimens for Tuberculosis
|
journal
|
November 2006 |
Apoptosis inMycobacterium tuberculosis infection in mice exhibiting varied immunopathology
|
journal
|
February 2000 |
Microfluidic source-sink model reveals effects of biophysically distinct CXCL12 isoforms in breast cancer chemotaxis
|
journal
|
January 2014 |
Macrophage Polarization Drives Granuloma Outcome during Mycobacterium tuberculosis Infection
|
journal
|
November 2014 |
Population Pharmacokinetics of Rifampin in Pulmonary Tuberculosis Patients, Including a Semimechanistic Model To Describe Variable Absorption
|
journal
|
April 2008 |
Prediction of Tumour Tissue Diffusion Coefficients of Hypoxia-Activated Prodrugs from Physicochemical Parameters
|
journal
|
January 2008 |
Comparison of activities of rifapentine and rifampin against Mycobacterium tuberculosis residing in human macrophages
|
journal
|
September 1995 |
Isoniazid Bactericidal Activity and Resistance Emergence: Integrating Pharmacodynamics and Pharmacogenomics To Predict Efficacy in Different Ethnic Populations
|
journal
|
April 2007 |
Modeling of Drug Release from Polymeric Delivery Systems?A Review;
|
journal
|
January 2004 |
Vaccine against tuberculosis: what’s new?
|
journal
|
January 2014 |
A systems perspective of host–pathogen interactions: predicting disease outcome in tuberculosis
|
journal
|
January 2010 |
A Physiologically Based Pharmacokinetic Model of Rifampin in Mice
|
journal
|
January 2013 |
A Physiologically Based Pharmacokinetic Model for Capreomycin
|
journal
|
December 2011 |
Population Modeling and Monte Carlo Simulation Study of the Pharmacokinetics and Antituberculosis Pharmacodynamics of Rifampin in Lungs
|
journal
|
April 2009 |
Origin of tuberculosis in the Paleolithic predicts unprecedented population growth and female resistance
|
journal
|
January 2020 |
Aging increases the systemic molecular degree of inflammatory perturbation in patients with tuberculosis
|
posted_content
|
March 2020 |
Optimizing Aminoglycoside Dosing Regimens for Critically Ill Pediatric Patients with Augmented Renal Clearance: a Convergence of Parametric and Nonparametric Population Approaches
|
journal
|
March 2021 |
Immunology of tuberculosis
|
journal
|
January 2012 |
Differences in reactivation of tuberculosis induced from anti-TNF treatments are based on bioavailability in granulomatous tissue
|
journal
|
January 2005 |
Tuberculous Granulomas Are Hypoxic in Guinea Pigs, Rabbits, and Nonhuman Primates
|
text
|
January 2008 |